having previously been criterium champion Stephen Clancy is one of Irish cycling’s longest serving pro cyclists, with the ...

Novo Nordisk, tje manufacturer behind Ozempic and Wegovy has another weight loss medication in the works — but according to ...

A pill Novo acquired produced modest weight loss but raised safety questions. Elsewhere, Sanofi detailed the silver lining it found in a recent study and a heart drug developer’s shares surged.

The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...

Novo Nordisk's U.S.-listed shares lost ground Friday after a study of the pharmaceutical firm’s latest obesity treatment ...

By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) -Novo Nordisk's shares fell nearly 5% on Friday after ...

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company focused on developing a potential new class of genetic medicines based on RNA editing for both rare and highly prevalent diseases, ...

Michael Matthews (Jayco-AlUla) powered to his third victory in the Grand Prix de Québec, out-sprinting Biniam Girmay ...

The Tour of Istanbul, the world’s only multi-stage international city cycling race, is set to pedal through the streets from Sept. 12-15, organized ...

WeightWatchers is remaking itself to appeal to both dieters and weight-loss medication users. But have consumers already lost ...